Stealth BioTherapeutics (MITO) PT Cut to $14 after Placebo Response was Higher Than Expected - Instinet
Tweet Send to a Friend
Nomura/Instinet Christopher Marai Buy Stealth BioTherapeutics (NASDAQ: MITO) price target of $14.00 (from $28.00) after the company announced that top-line ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
